Michael Jay Ross - 21 Oct 2021 Form 4 Insider Report for Xilio Therapeutics, Inc. (XLO)

Role
Director
Signature
/s/ Chris Frankenfield, attorney-in-fact for Michael Ross
Issuer symbol
XLO
Transactions as of
21 Oct 2021
Transactions value $
$0
Form type
4
Filing time
25 Oct 2021, 17:18:19 UTC
Next filing
17 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XLO Stock Option (right to buy) Award $0 +26,400 $0 26,400 21 Oct 2021 Common Stock 26,400 $16 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option award was granted on October 21, 2021 and will vest in three equal installments on October 21, 2022, October 21, 2023 and October 21, 2024.